Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristopher J Swiger

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Safety|May 21, 2015
PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trialsKristopher J Swiger, Seth S Martin
Current Treatment Options in Cardiovascular Medicine|March 17, 2017
Cardiomyopathic Toxicity From Chemotherapy: Is There an Opportunity for Preemptive Intervention?Kristopher J Swiger, Jai Singh, Daniel J Lenihan
Current Atherosclerosis Reports|November 16, 2014
Impact on cognitive function-are all statins the same?Nishant P Shah, Kristopher J Swiger, Seth S Martin
Clinical Cardiology|April 15, 2015
Cholesterol, statins, and dementia: what the cardiologist should knowBrett L Wanamaker, Kristopher J Swiger, Roger S Blumenthal, et al.
Current Cardiology Reports|April 18, 2013
Cigarette smoking and clopidogrel interactionKristopher J Swiger, Omair Yousuf, Kevin P Bliden, et al.
European Journal of Clinical Pharmacology|October 9, 2014
Statins, mood, sleep, and physical function: a systematic reviewKristopher J Swiger, Raoul J Manalac, Michael J Blaha, et al.
Mayo Clinic Proceedings|October 8, 2013
Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effectsKristopher J Swiger, Raoul J Manalac, Roger S Blumenthal, et al.
Clinical Cardiology|July 28, 2015
Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial InfarctionKristopher J Swiger, Seth S Martin, Fengming Tang, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 5, 2016
Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosisKristopher J Swiger, Eitan A Friedman, Evan L Brittain, et al.
Clinical and Experimental Emergency Medicine|July 13, 2019
Potential impact of cardiology phone-consultation for patients risk-stratified by the HEART pathwayKen Monahan, Margaret Pan, Chinonso Opara, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Safety|May 21, 2015
PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trialsKristopher J Swiger, Seth S Martin
Current Treatment Options in Cardiovascular Medicine|March 17, 2017
Cardiomyopathic Toxicity From Chemotherapy: Is There an Opportunity for Preemptive Intervention?Kristopher J Swiger, Jai Singh, Daniel J Lenihan
Current Atherosclerosis Reports|November 16, 2014
Impact on cognitive function-are all statins the same?Nishant P Shah, Kristopher J Swiger, Seth S Martin
Clinical Cardiology|April 15, 2015
Cholesterol, statins, and dementia: what the cardiologist should knowBrett L Wanamaker, Kristopher J Swiger, Roger S Blumenthal, et al.
Current Cardiology Reports|April 18, 2013
Cigarette smoking and clopidogrel interactionKristopher J Swiger, Omair Yousuf, Kevin P Bliden, et al.
European Journal of Clinical Pharmacology|October 9, 2014
Statins, mood, sleep, and physical function: a systematic reviewKristopher J Swiger, Raoul J Manalac, Michael J Blaha, et al.
Mayo Clinic Proceedings|October 8, 2013
Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effectsKristopher J Swiger, Raoul J Manalac, Roger S Blumenthal, et al.
Clinical Cardiology|July 28, 2015
Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial InfarctionKristopher J Swiger, Seth S Martin, Fengming Tang, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 5, 2016
Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosisKristopher J Swiger, Eitan A Friedman, Evan L Brittain, et al.
Clinical and Experimental Emergency Medicine|July 13, 2019
Potential impact of cardiology phone-consultation for patients risk-stratified by the HEART pathwayKen Monahan, Margaret Pan, Chinonso Opara, et al.
Pageof 2